Education
About Us
Working with TipRanks
Follow Us
Brady James Aloysius Insider Profile
4 Followers
Brady James Aloysius, Director at Verona Pharma, holds 0.00 shares in Verona Pharma (Ticker: VRNA), holds 100.00K shares in Xeris Pharmaceuticals (Ticker: XERS).
Brady James Aloysius Verona Pharma (VRNA)Director
Verona Pharma (VRNA)
Director
Not Ranked
Brady James Aloysius has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brady James Aloysius's holdings
Insider Roles
Director
Roles that Brady James Aloysius holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brady James Aloysius
Brady James Aloysius's Trading History
Verona Pharma
Oct 08, 2025
―
Uninformative Buy
7.70M
$0.00
Xeris Pharmaceuticals
Mar 28, 2025
Director
Uninformative Buy
―
$544.00K
List of latest transactions for each holding click on a transaction to see Brady James Aloysius's performance on stock
You May Also Like
Brady James Aloysius insider profile FAQ
What is the percentage of profitable transactions made by Brady James Aloysius?
The percentage of profitable transactions made by Brady James Aloysius is ―.
What is the average return per transaction made by Brady James Aloysius?
The average return per transaction made by Brady James Aloysius is ―.
What stocks does Brady James Aloysius hold?
Brady James Aloysius holds: VRNA, XERS stocks.
What was Brady James Aloysius’s latest transaction?
Brady James Aloysius latest transaction was an Uninformative Buy of $7.70M.
What was Brady James Aloysius's most profitable transaction?
Brady James Aloysius’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brady James Aloysius's role in Verona Pharma?
Brady James Aloysius's role in Verona Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.